Display options
Cite
Kass N, Taylor H, Fogarty L, et al. Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?. J Empir Res Hum Res Ethics. 2008;3(3):57-68doi: 10.1525/jer.2008.3.3.57.
Kass, N., Taylor, H., Fogarty, L., Sugarman, J., Goodman, S. N., Goodwin-Landher, A., Carducci, M., & Hurwitz, H. (2008). Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?. Journal of empirical research on human research ethics : JERHRE, 3(3), 57-68. https://doi.org/10.1525/jer.2008.3.3.57
Kass, Nancy, et al. "Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?." Journal of empirical research on human research ethics : JERHRE vol. 3,3 (2008): 57-68. doi: https://doi.org/10.1525/jer.2008.3.3.57
Kass N, Taylor H, Fogarty L, Sugarman J, Goodman SN, Goodwin-Landher A, Carducci M, Hurwitz H. Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?. J Empir Res Hum Res Ethics. 2008 Sep;3(3):57-68. doi: 10.1525/jer.2008.3.3.57. PMID: 19385771; PMCID: PMC2861824.
Copy Download .nbib Format: NLM
Share it on

J Empir Res Hum Res Ethics. 2008 Sep;3(3):57-68. doi: 10.1525/jer.2008.3.3.57.

Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?.

Journal of empirical research on human research ethics : JERHRE

Nancy Kass, Holly Taylor, Linda Fogarty, Jeremy Sugarman, Steven N Goodman, Annallys Goodwin-Landher, Michael Carducci, Herbert Hurwitz

Affiliations

  1. Johns Hopkins Berman Institute of Bioethics and Bloomberg School of Public Health.

PMID: 19385771 PMCID: PMC2861824 DOI: 10.1525/jer.2008.3.3.57

Abstract

CANCER PATIENTS OVERESTIMATE BENEFITS of early phase trials but studies have not reported what oncologists say to patients about trials. We audiotaped oncologists talking to cancer patients about Phase I or II trials and interviewed patients about the purpose and expected outcomes of trials presented to them. Oncologists gave mixed messages, saying Phase I trials measure safety and dosing, yet referring to trials as treatment with uncertain therapeutic effects. Seventeen percent of Phase I respondents said the trial's purpose related to safety/dosing (p = 0.017); 17% of Phase I respondents said the purpose was "to cure my cancer." Patients may find it important to believe trials offer significant benefit. Oncologists, while respecting patients' hopes, should be precise in their language, particularly regarding Phase I trials, distinguishing early stages of research from treatment.

References

  1. JAMA. 2003 Aug 27;290(8):1075-82 - PubMed
  2. JAMA. 2004 Nov 3;292(17):2130-40 - PubMed
  3. Med Decis Making. 1989 Oct-Dec;9(4):262-71 - PubMed
  4. J Clin Oncol. 1995 May;13(5):1062-72 - PubMed
  5. Soc Sci Med. 2004 Jan;58(2):379-90 - PubMed
  6. CMAJ. 2001 Jul 24;165(2):174-9 - PubMed
  7. JAMA. 1982 Jul 16;248(3):344-8 - PubMed
  8. Ann Intern Med. 2003 Mar 4;138(5):439-43 - PubMed
  9. J Adv Nurs. 2001 Mar;33(6):738-47 - PubMed
  10. Hastings Cent Rep. 2000 Jul-Aug;30(4):34-43 - PubMed
  11. Cancer Treat Rep. 1986 Sep;70(9):1105-15 - PubMed
  12. J Pers. 1987 Jun;55(2):169-210 - PubMed
  13. Eur J Cancer. 1999 Aug;35(8):1187-93 - PubMed
  14. N Engl J Med. 2005 Mar 3;352(9):895-904 - PubMed
  15. Lancet. 2001 Nov 24;358(9295):1772-7 - PubMed
  16. Oncol Nurs Forum. 2000 Oct;27(9):1435-8 - PubMed
  17. IRB. 2000 May-Jun;22(3):6-14 - PubMed
  18. Hastings Cent Rep. 1996 Sep-Oct;26(5):25-9 - PubMed
  19. IRB. 1998 Jul-Aug;20(4):1-7 - PubMed
  20. Cancer. 2004 Mar 15;100(6):1276-82 - PubMed
  21. Eur J Cancer Clin Oncol. 1984 Apr;20(4):457-62 - PubMed
  22. Ann Oncol. 2000 Mar;11(3):289-94 - PubMed
  23. JAMA. 1982 Aug 27;248(8):968-70 - PubMed
  24. Health Educ Monogr. 1977 Winter;5(4):281-315 - PubMed
  25. J Clin Oncol. 1996 Jan;14(1):287-95 - PubMed
  26. Am Psychol. 2000 Jan;55(1):99-109 - PubMed
  27. Invest New Drugs. 1991 Feb;9(1):115-22 - PubMed
  28. J Clin Oncol. 2000 Jan;18(2):421-8 - PubMed

Publication Types

Grant support